Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
What's the dividend yield in case it drops that low?
Buy Wednesday wohoo
Your alive!!
Private? What he thinks he's special??! Lol
Whatever happened to 8? He disappeared
Statement of Changes in Beneficial Ownership (4)
Source: Edgar (US Regulatory)
FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
1. Name and Address of Reporting Person *
Albert Harold 2. Issuer Name and Ticker or Trading Symbol
PROFIRE ENERGY INC [ PFIE ] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable)
__ X __ Director __ X __ 10% Owner
__ X __ Officer (give title below) _____ Other (specify below)
Chief Technology Officer
(Last) (First) (Middle)
BAY 12, 55 ALBERTA AVENUE 3. Date of Earliest Transaction (MM/DD/YYYY)
11/2/2016
(Street)
SPRUCE GROVE, A0 T7X 3A6
(City) (State) (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)
6. Individual or Joint/Group Filing (Check Applicable Line)
_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) 8. Price of Derivative Security
(Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock Option (right to buy) $1.17 11/2/2016 A 75000 (1) 11/2/2019 Common Stock 75000 $0 75000 D
Explanation of Responses:
( 1) The options vest in two equal annual installments beginning on November 2, 2017.
Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Albert Harold
BAY 12
55 ALBERTA AVENUE
SPRUCE GROVE, A0 T7X 3A6 X X Chief Technology Officer
Signatures
/s/ Todd Fugal, attorney-in-fact for Harold Albert 11/4/2016
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
I get enough abuse from PFIE.. lol
No worries I was being sarcastic..
Yes dumb but too late for all that
Wtf $1.08?
We need news!!
Wow $3.5!!
$4 AH!
It's because I sold .. your welcome
What are we supposed to do email him our names?!! Lol
So we have to contact them via email to get part of the new company?
Picked up some at 7.4 nice bounce
I can't help myself I'm so inpatient I don't think I can wait until next week to add! Lol I may add here
Damn wtf I guess it need to correct it self to be in line with the others that have fallen
Yeah that's why I was asking not sure to add now , or after election next week or wait until December hike..
So we will get free shares of a second company?!! Woohoo
Wait what two companies?
Do you remember when the best time to add was it in December or January when was the big drop from the fed hike?
Yes production show me the money$$
Anyone know when they are supposed to break ground?
Takeda halted deal in place?
Ouch lower tomorrow on inventory build of crude
"In accordance with its duties to shareholders and other stakeholders, management evaluates any transaction relating to core or non-core business units in accordance with the best interest of its shareholders and stakeholders. We are currently in discussions with third parties for various divestitures including but not limited to Salix. The discussions may or may not lead to a definitive agreement. Valeant does not intend to comment further on market speculation or disclose any developments unless and until it otherwise deems further disclosure is appropriate or required.
Where's that Wells Fargo guy?!! Lmao
Lmao!! Instead of working on all these other dumb inventions and accessories why don't they make a prototype or two?!! Scam
What just happened that we are 12% up?
Hope we get good numbers this afternoon..
Oil is up today so far and chk red!!
What's your point? Debt is not the reason why we had the drop today. Manipulation was
Valeant Pharmaceuticals Comments On Press Report
Source: PR Newswire (Canada)
LAVAL, Quebec, Oct. 31, 2016 /CNW/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) ("Valeant") today issued the following statement regarding comments attributed to anonymous sources in a press report regarding the ongoing investigation being conducted by the U.S. Attorney's Office for the Southern District of New York:
"As Valeant previously stated in response to a prior, similar press report, the Company previously disclosed in October 2015 that the United States Attorney's Office for the Southern District of New York commenced an investigation involving Valeant. We have been fully cooperating with the authorities throughout the investigation, and we are in frequent contact and continue to cooperate with the U.S. Attorney's Office for the Southern District of New York. We do not comment on rumors about investigations, and cannot comment on or speculate about the possible course of any ongoing investigation.
"Valeant takes these matters seriously and intends to uphold the highest standards of ethical conduct as we move forward with our mission to improve people's lives with our healthcare products."
About Valeant
Valeant Pharmaceuticals International, Inc. (NYSE/TSX:VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, gastrointestinal disorders, eye health, neurology and branded generics. More information about Valeant can be found at www.valeant.com.
Contact Information:
Elif McDonald
elif.mcdonald@valeant.com
514-856-3855
877-281-6642 (toll free)
Media:
Renée Soto
or
Chris Kittredge/Jared Levy
Sard Verbinnen & Co.
212-687-8080
Valeant Pharmaceuticals International, Inc.
Logo - http://photos.prnewswire.com/prnh/20101025/LA87217LOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/valeant-pharmaceuticals-comments-on-press-report-300354317.html
SOURCE Valeant Pharmaceuticals International, Inc.
Copyright 2016 Canada NewsWire
Damn shorts out in full force with old news lol
Nothing new.. we already knew about the investigation
Hi-Crush Partners LP Announces Launch of PropStream(TM) and Investment in PropX
Ackman sell?